Mark S. Ordan
Chief Executive Officer at Pediatrix Medical Group Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Pediatrix Medical Group Inc., 3 years.
Pediatrix Medical Group Inc.
Director · Chief Executive Officer
The Carlyle Group Inc.
Director
Chief executive roles
Pediatrix Medical Group Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 9, 2024 | Pediatrix Medical Group Inc. | Grant or award | +18,360 | — | — |
| May 1, 2024 | The Carlyle Group Inc. | Grant or award | +5,004 | — | — |
| May 25, 2023 | Pediatrix Medical Group Inc. | Open-market sale | −33,000 | $13.26 | $437,580 |
| May 11, 2023 | Pediatrix Medical Group Inc. | Grant or award | +9,463 | — | — |
| May 1, 2023 | The Carlyle Group Inc. | Grant or award | +6,238 | — | — |
| Dec 31, 2022 | Pediatrix Medical Group Inc. | Shares withheld for tax | −98,932 | $14.86 | $1,470,130 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.